Skip to main content
. 2020 Dec 31;113(3):706–715. doi: 10.1093/ajcn/nqaa334

TABLE 2.

Baseline characteristics of sample stratified by baseline calibrated energy (kcal/d) and total protein (g/d) quartiles

Calibrated energy <1917.3 kcal/d, n = 841 Calibrated energy 1917.3 to <2071.2 kcal/d, n = 842 Calibrated energy 2071.2 to <2245.3 kcal/d, n = 842 Calibrated energy ≥2245.3 kcal/d, n = 842 Calibrated total protein <66.3 g/d, n = 841 Calibrated total protein 66.3 to <73.4 g/d, n = 842 Calibrated total protein 73.4 to <81.7 g/d, n = 843 Calibrated total protein ≥81.7 g/d, n = 841
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Age, years
 50–59 23 (2.7) 127 (15.1) 321 (38.1) 494 (58.7) 70 (8.3) 154 (18.3) 307 (36.4) 434 (51.6)
 60–69 326 (38.8) 457 (54.3) 427 (50.7) 309 (36.7) 346 (41.1) 429 (51.0) 395 (46.9) 349 (41.5)
 70–79 492 (58.5) 258 (30.6) 94 (11.2) 39 (4.6) 425 (50.5) 259 (30.8) 141 (16.7) 58 (6.9)
Race/ethnicity
 Non-Hispanic White 327 (38.9) 447 (53.1) 453 (53.8) 421 (50.0) 259 (30.8) 399 (47.4) 460 (54.6) 530 (63.0)
 Non-Hispanic Black/African American 91 (10.8) 160 (19.0) 187 (22.2) 321 (38.1) 284 (33.8) 178 (21.1) 167 (19.8) 130 (15.5)
 Hispanic/Latina 171 (20.3) 115 (13.7) 95 (11.3) 43 (5.1) 118 (14.0) 116 (13.8) 102 (12.1) 88 (10.5)
 Asian/Pacific Islander 217 (25.8) 89 (10.6) 53 (6.3) 7 (0.8) 155 (18.4) 113 (13.4) 68 (8.1) 30 (3.6)
 American Indian/Alaskan Native 27 (3.2) 26 (3.1) 37 (4.4) 40 (4.8) 20 (2.4) 30 (3.6) 31 (3.7) 49 (5.8)
 Unknown 8 (1.0) 5 (0.6) 17 (2.0) 10 (1.2) 5 (0.6) 6 (0.7) 15 (1.8) 14 (1.7)
BMI, kg/m2
 Underweight, <18.5 39 (4.6) 8 (1.0) 3 (0.4) 0 (0.0) 28 (3.3) 13 (1.5) 6 (0.7) 3 (0.4)
 Normal weight, 18.5–24.9 550 (65.4) 345 (41.0) 202 (24.0) 36 (4.3) 441 (52.4) 335 (39.8) 235 (27.9) 122 (14.5)
 Overweight, 25–29.9 235 (17.9) 390 (46.3) 394 (46.8) 194 (23.0) 280 (33.3) 333 (39.5) 344 (40.8) 256 (30.4)
 Obese, ≥30 17 (2.0) 99 (11.8) 243 (28.9) 612 (72.7) 92 (10.9) 161 (19.1) 258 (30.6) 460 (54.7)
Smoking
 Current 77 (9.2) 71 (8.4) 58 (6.9) 39 (4.6) 71 (8.4) 66 (7.8) 63 (7.5) 45 (5.4)
 Past 243 (28.9) 300 (35.6) 344 (40.9) 348 (41.3) 278 (33.1) 308 (36.6) 313 (37.1) 336 (40.0)
 Never 521 (62.0) 471 (55.9) 440 (52.3) 455 (54.0) 492 (58.5) 468 (55.6) 467 (55.4) 460 (54.7)
Education
 High school/GED or less 220 (26.2) 213 (25.3) 173 (20.5) 212 (25.2) 270 (32.1) 208 (24.7) 183 (21.7) 157 (18.7)
 School after high school 306 (36.4) 297 (35.3) 342 (40.6) 323 (38.4) 248 (29.5) 280 (33.3) 332 (39.4) 408 (48.5)
 College degree or higher 315 (37.5) 332 (39.4) 327 (38.8) 307 (36.5) 323 (38.4) 354 (42.0) 328 (38.9) 276 (32.8)
Parity
 Never pregnant/no term pregnancy 131 (15.6) 82 (9.7) 84 (10.0) 83 (9.9) 152 (18.1) 87 (10.3) 88 (10.4) 53 (6.3)
 1 55 (6.5) 72 (8.6) 80 (9.5) 114 (13.5) 133 (15.8) 91 (10.8) 66 (7.8) 31 (3.7)
 2 227 (27.0) 200 (23.8) 183 (21.7) 165 (19.6) 261 (31.0) 221 (26.2) 176 (20.9) 117 (13.9_
 3 251 (29.8) 207 (24.6) 188 (22.3) 151 (17.9) 181 (21.5) 211 (25.1) 209 (24.8) 196 (23.3)
 4 74 (8.8) 118 (14.0) 164 (19.5) 169 (20.1) 78 (9.3) 137 (16.3) 132 (15.7) 178 (21.2)
 ≥5 103 (12.2) 163 (19.4) 143 (17.0) 160 (19.0) 36 (4.3) 95 (11.3) 172 (20.4) 266 (31.6)
Recreational physical activity, moderate or strenuous, times/week
 No activity 122 (14.5) 144 (17.1) 128 (15.2) 172 (20.4) 155 (18.4) 127 (15.1) 142 (16.8) 142 (16.9)
 Some activity 385 (45.8) 332 (39.4) 352 (41.8) 371 (44.1) 379 (45.1) 342 (40.6) 358 (42.5) 361 (42.9)
 2 to <4 episodes 138 (16.4) 143 (17.0) 153 (18.2) 139 (16.5) 134 (15.9) 148 (17.6) 140 (16.6) 151 (18.0)
 ≥4 episodes 196 (23.3) 223 (26.5) 209 (24.8) 160 (19.0) 173 (20.6) 225 (26.7) 203 (24.1) 187 (22.2)
Study component
 Observational study 449 (53.4) 342 (40.6) 272 (32.3) 206 (24.5) 413 (49.1) 350 (41.6) 276 (32.7) 230 (27.3)
 Clinical trial 392 (46.6) 500 (59.4) 570 (67.7) 636 (75.5) 428 (50.9) 492 (58.4) 567 (67.3) 611 (72.7)
 DM 220 (26.2) 293 (34.8) 348 (41.3) 397 (47.1) 249 (29.6) 314 (37.3) 340 (40.3) 355 (42.2)
 HT 233 (27.7) 283 (33.6) 334 (39.7) 391 (46.4) 255 (30.3) 261 (31.0) 332 (39.4) 393 (46.7)
Cardiovascular disease
 Yes 21 (2.5) 16 (1.9) 15 (1.8) 22 (2.6) 16 (1.9) 21 (2.5) 17 (2.0) 20 (2.4)
 No 820 (97.5) 826 (98.1) 827 (98.2) 820 (97.4) 825 (98.1) 821 (97.5) 826 (98.0) 821 (97.6)
Diabetes
 Yes 21 (2.5) 29 (3.4) 31 (3.7) 40 (4.8) 7 (0.8) 19 (2.3) 28 (3.3) 67 (8.0)
 No 820 (97.5) 813 (96.6) 811 (96.3) 920 (95.2) 834 (92.8) 823 (97.7) 815 (96.7) 774 (92.0)
Hypertension1
 Yes 359 (42.7) 326 (38.7) 323 (38.4) 337 (40.0) 394 (46.8) 330 (39.2) 294 (34.9) 327 (38.9)
 No 482 (57.3) 516 (61.3) 519 (61.6) 505 (60.0) 447 (53.2) 512 (60.8) 549 (65.1) 514 (61.1)
Dyslipidemia2
 Yes 302 (36.2) 306 (36.5) 328 (39.2) 369 (44.0) 279 (33.3) 310 (37.0) 322 (38.4) 394 (47.0)
 No 539 (63.8) 536 (63.5) 514 (60.8) 473 (56.0) 562 (66.7) 532 (63.0) 521 (61.6) 447 (53.0)
  Missing 6 (0.7) 3 (0.4) 5 (0.6) 3 (0.4) 4 (0.5) 5 (0.6) 5 (0.6) 3 (0.4)
Biometrics, mean ± SD
 Triglycerides, mg/dL 127.7 ± 58.9 124.9 ± 61.5 126.2 ± 62.2 125.7 ± 57.9 118.6 ± 53.3 126.6 ± 62.7 124.8 ± 58.6 134.5 ± 64.3
 HDL, mg/dL 63.0 ± 15.1 61.3 ± 14.9 59.6 ± 13.7 56.1 ± 12.0 62.9 ± 15.3 61.2 ± 14.6 59.3 ± 13.6 56.6 ± 12.3
 Fasting blood glucose, mg/dL 95.4 ± 19.5 94.9 ± 19.3 95.9 ± 23.7 99.0 ± 27.7 93.8 ± 14.1 95.3 ± 17.3 95.9 ± 24.5 100.3 ± 31.1
 Waist: hip ratio 0.80 ± 0.10 0.80 ± 0.07 0.81 ± 0.07 0.82 ± 0.08 0.80 ± 0.10 0.80 ± 0.07 0.80 ± 0.07 0.82 ± 0.08
 Waist circumference, cm 77.1 ± 9.4 81.8 ± 9.4 85.7 ± 10.9 96.4 ± 13.8 79.6 ± 10.5 82.7 ± 11.3 85.6 ± 11.8 93.1 ± 14.6
Energy, kcal/d, geometric mean (95% CI)
 Uncalibrated 1276.1 (1246.1–1306.8) 1403.8 (1369.9–1438.6) 1494.1 (1457.8–1531.4) 1618.6 (1576.7–1661.7) 1148.9 (1122.6–1175.8) 1380.4 (1349.5–1412.0) 1520.6 (1486.1–1555.8) 1796.7 (1755.2–1839.2)
 Calibrated 1802.5 (1796.7–1808.4) 1993.2 (1990.2–1996.2) 2151.9 (2148.5–2155.2) 2438.6 (2426.1–2451.1) 1871.9 (1861.1–1882.8) 2012.6 (2001.9–2023.4) 2140.3 (2128.1–2152.5) 2338.5 (2322.3–2354.7)
Total protein, g/d, geometric mean (95% CI)
 Uncalibrated 51.7 (50.3–53.1) 57.7 (56.1–59.3) 61.8 (60.2–63.5) 66.5 (64.6–68.5) 44.3 (43.1–45.5) 56.1 (54.7–57.5) 63.4 (61.9–65.0) 77.9 (76.0–79.8)
 Calibrated 63.4 (63.0–63.9) 70.7 (70.2–71.2) 76.7 (76.1–77.2) 84.9 (84.1–85.6) 60.3 (59.9–60.6) 69.8 (69.7–70.0) 77.3 (77.1–77.4) 89.8 (89.3–90.3)
Animal protein, g/d, geometric mean (95% CI)
 Uncalibrated 32.1 (30.9–33.3) 38.1 (36.8–39.5) 41.5 (40.1–42.8) 45.6 (44.4–47.5) 27.1 (26.1–28.1) 36.8 (35.8–37.9) 42.7 (41.5–44.0) 54.7 (53.1–56.2)
 Estimated3 39.4 (38.6–40.2) 46.7 (45.9–47.5) 51.4 (50.6–52.2) 58.6 (57.7–59.4) 36.9 (36.1–37.7) 45.9 (45.3–46.4) 52.0 (51.4–52.7) 63.0 (62.3–63.8)
Vegetable protein, g/d, geometric mean (95% CI)
 Uncalibrated 17.6 (17.1–18.1) 17.9 (17.4–18.4) 18.8 (18.3–19.3) 19.1 (18.6–19.7) 15.3 (14.9–15.8) 17.8 (17.3–18.3) 19.1 (18.6–19.6) 21.7 (21.1–22.3)
 Estimated3 21.6 (21.1–22.1) 21.9 (21.5–22.4) 23.3 (22.8–23.8) 24.4 (23.9–24.9) 20.9 (20.4–21.4) 22.2 (21.7–22.7) 23.3 (22.8–23.8) 25.0 (24.5–25.5)

For categorical variables, percentages are based on known values. Variables with no missing values do not have a “missing” row. Abbreviations: DM, Dietary Modification Trial; HT, Hormone Therapy Trial.

1

Hypertension, or high blood pressure, was defined as systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg.

2

Dyslipidemia was defined as triglycerides ≥150 mg/dL or HDL <50 mg/dL.

3

Estimated by multiplying the biomarker-based calibrated total protein intake by the self-reported protein subtype proportion.